Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer.

Front Immunol · 2023 · PMC10008925 · PMID 36923407

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

We performed GO and KEGG enrichment analysis of FAM110A-related genes in LIHC and found highly significant enrichment of GO terms associated with immune function, including interferon-γ production, T cell activation, B cell activation, adaptive immune response, mast cell-mediated immunity, and positive regulation of cell activation.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.